Stocks · Technology · Services-Computer Processing & Data Preparation

Hinge Health, Inc.

HNGE Clue Score28
United States Fiscal year ends December CIK 0001673743
$102.90 +5.00% Close, 9 Oct 2026
Price $102.90 +104.33% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 22 May 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2023Revenue292.7Operating income−130.5Net income−108.1EPS, diluted−8.31Fiscal year 2024Revenue390.4 +33.4%Operating income−31.9Net income−11.9EPS, diluted−0.88Fiscal year 2025Revenue587.9 +50.6%Operating income−546.4Net income−528.3EPS, diluted−7.77
FY2023FY2024FY2025
Revenue 292.7 390.4 587.9
Growth +33.4% +50.6%
Operating income −130.5 −31.9 −546.4
Net income −108.1 −11.9 −528.3
Growth
EPS, diluted −8.31 −0.88 −7.77

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2023Gross margin66.3%Operating margin−44.6%Net margin−36.9%Free cash flow margin−22.5%Fiscal year 2024Gross margin76.8%Operating margin−8.2%Net margin−3.1%Free cash flow margin12.3%Fiscal year 2025Gross margin79.6%Operating margin−92.9%Net margin−89.9%Free cash flow margin29.0%
FY2023FY2024FY2025
Gross margin 66.3% 76.8% 79.6%
Operating margin −44.6% −8.2% −92.9%
Net margin −36.9% −3.1% −89.9%
Free cash flow margin −22.5% 12.3% 29.0%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2023Operating cash flow−63.9Capital expenditure−2.0Free cash flow−65.9Buybacks0.0Fiscal year 2024Operating cash flow49.0Capital expenditure−1.0Free cash flow48.0Buybacks0.0Fiscal year 2025Operating cash flow171.4Capital expenditure−0.7Free cash flow170.7 +256.0%Buybacks−65.0
FY2023FY2024FY2025
Operating cash flow −63.9 49.0 171.4
Capital expenditure −2.0 −1.0 −0.7
Free cash flow −65.9 48.0 170.7
Growth +256.0%
Buybacks 0.0 0.0 −65.0

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2023Cash235.0Shareholders’ equity−424.0Fiscal year 2024Cash300.8Shareholders’ equity−434.6Fiscal year 2025Cash208.0Shareholders’ equity178.7
FY2023FY2024FY2025
Cash 235.0 300.8 208.0
Shareholders’ equity −424.0 −434.6 178.7

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025† 31 Dec 2025
Assets
235.0 300.8 208.0
n/a 42.5 66.1
n/a 10.9 15.6
n/a 7.4 10.5
n/a 61.6 64.1
n/a 673.3 744.8
Growth +10.6%
Liabilities
n/a 256.6 366.2
Equity
n/a −522.7 −1,051.0
−424.0 −434.6 178.7
Growth
Per share and net cash
n/a 16.4 0.0
calc n/a −26.53 n/a

† The diluted share count jumps at 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how.